Galiullin A R, Khakamova G A, Uliamaeva V V, Latypova G A, Gur'ev D A, Volevach L V
Eksp Klin Gastroenterol. 2010(4):109-13.
The therapeutic efficacy of duspatalin was evaluated in 72 patients with chronic cholecystitis and dyskinesia of the biliary tract (BT). Supplementation of duspatalin to the combined therapy in the patients with chronic cholecystitis shown to exert a pronounced therapeutic effect. This caused positive changes in clinical symptoms and BT function and quality of life, diminished the lithogenic properties of bile.
在72例慢性胆囊炎和胆道运动障碍（BT）患者中评估了度司帕他林的治疗效果。在慢性胆囊炎患者的联合治疗中添加度司帕他林显示出显著的治疗效果。这使临床症状、BT功能和生活质量产生了积极变化，降低了胆汁的成石特性。
